| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/05/2003 | CA2362917C Methods for anti-tumor therapy |
| 08/05/2003 | CA2115943C Novel process for the preparation of cetrorelix lyophilisate |
| 08/05/2003 | CA2079374C (bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 07/31/2003 | WO2003062467A2 Tissue rejection |
| 07/31/2003 | WO2003062390A2 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling |
| 07/31/2003 | WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR |
| 07/31/2003 | WO2003062276A2 Multimers of receptor-binding ligands |
| 07/31/2003 | WO2003062275A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | WO2003062274A1 Novel proteins and dnas thereof |
| 07/31/2003 | WO2003062252A1 Edg receptor agonists |
| 07/31/2003 | WO2003062245A1 Fused bicyclic pyrimidine derivatives |
| 07/31/2003 | WO2003062241A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/31/2003 | WO2003062236A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES |
| 07/31/2003 | WO2003062203A1 Method |
| 07/31/2003 | WO2003061700A1 Remedies for chronic kidney diseases |
| 07/31/2003 | WO2003061696A2 Systems and methods for photodynamic therapy |
| 07/31/2003 | WO2003061587A2 USE OF TGF-β ANTAGONISTS TO TREAT OR TO PREVENT CHRONIC TRANSPLANT REJECTION |
| 07/31/2003 | WO2003061573A2 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo |
| 07/31/2003 | WO2003040339A3 Antisense modulation of purinoreceptor p2x¿3? |
| 07/31/2003 | WO2003018545B1 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3? |
| 07/31/2003 | WO2002094767A3 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |
| 07/31/2003 | WO2002094202B1 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 07/31/2003 | WO2002064627A3 Crystallization of igf-1 |
| 07/31/2003 | WO2002062762A3 Potassium channel openers |
| 07/31/2003 | WO2002060875A8 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 07/31/2003 | WO2002030863A3 Ether compounds and compositions for cholesterol management and related uses |
| 07/31/2003 | WO2002029038A3 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 07/31/2003 | WO2002024909A3 Receptor nucleic acids and polypeptides |
| 07/31/2003 | WO2002018444A3 Erbb4 antagonists |
| 07/31/2003 | US20030144529 Treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula I Mitogen-activated protein kinases (MAP) is a family of proline- directed serine/threonine kinases that activate their |
| 07/31/2003 | US20030144352 Antimuscarinic aerosol |
| 07/31/2003 | US20030144346 Methods and compositions for regulation of 5-alpha reductase activity |
| 07/31/2003 | US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/31/2003 | US20030144326 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 07/31/2003 | US20030144309 Inhibitors of Src and other protein kinases |
| 07/31/2003 | US20030144302 Process for making substituted pyrazoles |
| 07/31/2003 | US20030144300 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 07/31/2003 | US20030144293 N-alkyl-adamantyl triazinyl benzamide derivatives |
| 07/31/2003 | US20030144290 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives |
| 07/31/2003 | US20030144280 Heterocyclic imines, used as cyclooxygenase inhibitors, administered as inflammatory and pain relievers in disorders such as arthritis, neurodegeneration or cancer in mammals |
| 07/31/2003 | US20030144279 5-Heterocyclo-pyrazoles |
| 07/31/2003 | US20030144270 Neurokinin receptor antagonists comprising heterocyclic amides used as antiemetics, antidepressants and/or antitussive agents |
| 07/31/2003 | US20030144267 Novel compounds |
| 07/31/2003 | US20030144252 Bicalutamide and N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4 -amine used as inhibitor of prostate cancer |
| 07/31/2003 | US20030144210 Treatment of neurologic and psychiatric disorders |
| 07/31/2003 | US20030144206 Combined use of a GLP-1 compound and modulator of diabetic late complications |
| 07/31/2003 | US20030144203 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/31/2003 | US20030144188 Androgen regulated nucleic acid molecules and encoded proteins |
| 07/31/2003 | US20030143676 Receptor polypeptides and polynucleotides encoding such polypeptides; for treating a disorder characterized by an elevated level of osteopontin |
| 07/31/2003 | US20030143589 Drug metabolizing enzymes |
| 07/31/2003 | US20030143286 Canine health diet |
| 07/31/2003 | US20030143278 Vaginal delivery of drugs |
| 07/31/2003 | US20030143271 For therapy and prophylaxis of cyclooxygenase-2 mediated disorder and for providing cardioprotection |
| 07/31/2003 | US20030143246 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 07/31/2003 | US20030143226 For therapy of arteriosclerosis, thrombocytopenia, kidneyd iseases, various types of inflammation such as myocardial ischemic reperfusion injury, inflammatory reactions after percutaneous transluminal coronary recanalization (PTCR)) |
| 07/31/2003 | US20030143207 Remodeling of tissues and organ |
| 07/31/2003 | CA2510751A1 Multimers of receptor-binding ligands |
| 07/31/2003 | CA2476773A1 Monoclonal antibodies against extracellular loops of c5ar |
| 07/31/2003 | CA2473924A1 Systems and methods for photodynamic therapy |
| 07/31/2003 | CA2473829A1 Use of tgf-.beta. antagonists to treat or to prevent chronic transplant rejection |
| 07/31/2003 | CA2473781A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | CA2473386A1 Method |
| 07/31/2003 | CA2472835A1 Fused bicyclic pyrimidine derivatives |
| 07/31/2003 | CA2471342A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/30/2003 | EP1331224A1 Thiazole or oxazole derivatives |
| 07/30/2003 | EP1330468A1 Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids |
| 07/30/2003 | EP1330455A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 07/30/2003 | EP1330451A2 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 07/30/2003 | EP1330448A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 07/30/2003 | EP1330444A2 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof |
| 07/30/2003 | EP1330293A2 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same |
| 07/30/2003 | EP1330257A1 Gnrh analogues for treatment of urinary incontinence |
| 07/30/2003 | EP1330255A2 Use of a preparation of cimicifuga racemosa |
| 07/30/2003 | EP0910400B1 Therapies for chronic renal failure |
| 07/30/2003 | EP0902022B1 Novel benzofuranone derivatives and process for producing the same |
| 07/30/2003 | CN1433424A 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 07/30/2003 | CN1433412A Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/30/2003 | CN1433405A Quinazoline compounds |
| 07/30/2003 | CN1432396A Chinese medicine prepn for treating nephropathy and its prepn |
| 07/30/2003 | CN1432370A Formula and production process of product capable of suppressing prostate hyperplasia |
| 07/30/2003 | CN1116072C Chinese medicine recipe for treating nephritis |
| 07/30/2003 | CN1116059C Shenxian capsule |
| 07/30/2003 | CN1116049C Traditional chinese medicine for curing non gonococcal urethritis |
| 07/29/2003 | US6600043 Carboxylic acid derivatives, their preparation and use |
| 07/29/2003 | US6599925 Cardiovascular disorders; anticancer agents |
| 07/29/2003 | US6599910 Substituted triazole compounds |
| 07/29/2003 | US6599879 Therapeutic uses of keratinocyte growth factor-2 |
| 07/29/2003 | US6599876 Medicament and method for treating renal disease |
| 07/29/2003 | US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods |
| 07/29/2003 | US6599540 Use of a Serenoa repens extract for the production of a medicament to treat prostate cancer |
| 07/29/2003 | US6599508 Truncated papillomavirus L1 protein, vaccine |
| 07/29/2003 | US6599499 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 07/29/2003 | CA2244621C 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor antagonists |
| 07/29/2003 | CA2185036C Use of a non photosynthetic filamentous bacteria extract and composition containing the same |
| 07/29/2003 | CA2123514C Novel benzothiophene derivative |
| 07/24/2003 | WO2003060521A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 07/24/2003 | WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | WO2003060148A2 Androgen regulated nucleic acid molecules and encoded proteins |
| 07/24/2003 | WO2003060071A2 Albumin fusion proteins |
| 07/24/2003 | WO2003059899A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |